Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

January 11, 2000

Eli Lilly and Co. Recalls Kefurox and  Mandol Injections

Indianapolis, IN (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Eli Lilly and Company is recalling Kefurox(r), Cefuroxime for Injection and Mandol(r), Cefamandole Nafate for Injection because of lack of assurance of sterility.

The Kefurox(r), USP, 1.5 g, a prescription broad spectrum antibiotic with NDC #0002-7272-10 bears the lot number of   S7750Y1.

The Mandol(r), USP, 1 g, a prescription broad spectrum antibiotic with NDC #0002-7061-25 bears the lot number of   S2556Y1.

According to FDA, 73,955 vials were distributed nationwide and in Santo Domingo.

This ongoing Class II recall was initiated by Eli Lilly and Company by fax, mail and United Parcel Service on October 22, 1999.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
Recall #D-193/194-0

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.